| 2024-04-11 | Sale | Travere Therapeutics, Inc. TVTX | CHIEF FINANCIAL OFFICER | 54 <0.0001% | $6.74 | $364 | -1.19% | |
| 2024-02-01 | Sale | Travere Therapeutics, Inc. TVTX | CHIEF FINANCIAL OFFICER | 3,818 0.0048% | $8.53 | $32,573 | -15.81% | |
| 2024-01-23 | Sale | Travere Therapeutics, Inc. TVTX | CHIEF FINANCIAL OFFICER | 853 0.0011% | $9.07 | $7,735 | -20.65% | |
| 2023-09-05 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 457 0.0006% | $14.71 | $6,723 | -46.51% | |
| 2023-05-10 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 455 0.0007% | $16.59 | $7,548 | -46.71% | |
| 2023-04-11 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 47 <0.0001% | $21.49 | $1,010 | -56.91% | |
| 2023-02-01 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 1,588 0.0023% | $21.75 | $34,542 | -30.53% | |
| 2023-01-24 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 852 0.0013% | $21.90 | $18,663 | -28.72% |